Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,372 | -4,980 | 21,666 | 23,468 | 24,544 |
| Depreciation Amortization | 1,427 | 681 | 3,172 | 2,510 | 1,782 |
| Income taxes - deferred | -5,437 | -1,910 | -2,294 | 546 | -719 |
| Accounts receivable | 3,882 | 2,424 | 2,448 | 1,311 | 2,285 |
| Accounts payable and accrued liabilities | 688 | -1,290 | 1,451 | 677 | 1,160 |
| Other Working Capital | 8,595 | 6,398 | 6,171 | 6,490 | 10,340 |
| Other Operating Activity | 1,360 | 1,822 | 3,195 | 2,933 | 655 |
| Operating Cash Flow | $143 | $3,145 | $35,809 | $37,935 | $40,047 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,531 | -953 | -4,738 | -4,323 | -3,710 |
| Purchase Of Investment | -151,273 | -73,671 | -192,429 | -150,490 | -84,561 |
| Sale Of Investment | 155,475 | 75,489 | 153,504 | 117,297 | 82,182 |
| Investing Cash Flow | $2,671 | $865 | $-43,663 | $-37,516 | $-6,089 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -36 | -18 | -68 | -50 | -33 |
| Common Stock Issued | 58 | 49 | 1,026 | 945 | 661 |
| Other Financing Activity | -202 | 0 | 1,747 | 1,749 | 48 |
| Financing Cash Flow | $-180 | $31 | $2,705 | $2,644 | $676 |
| Beginning Cash Position | 16,577 | 16,577 | 21,726 | 21,726 | 21,726 |
| End Cash Position | 19,211 | 20,618 | 16,577 | 24,789 | 56,360 |
| Net Cash Flow | $2,634 | $4,041 | $-5,149 | $3,063 | $34,634 |
| Free Cash Flow | |||||
| Operating Cash Flow | 143 | 3,145 | 35,809 | 37,935 | 40,047 |
| Capital Expenditure | -1,531 | -953 | -4,738 | -4,323 | -3,710 |
| Free Cash Flow | -1,388 | 2,192 | 31,071 | 33,612 | 36,337 |